Valerion Therapeutics' Debt Round

Valerion Therapeutics raised a round of funding on June 18, 2010. Investors include Massachusetts Life Sciences Center.

Valerion Therapeutics, formelry 4s3 Bioscience, is a biotechnology company focused on developing genetic disease therapies for orphan neuromuscular disorders. The company's platform is an antibody-bas…

Articles about Valerion Therapeutics' Debt Round: